NCT06857253View on ClinicalTrials.gov

A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS-1301 in Healthy Subjects

PHASE1RecruitingINTERVENTIONAL

Enrollment

82

Participants

Timeline

Start Date

March 18, 2025

Primary Completion Date

July 31, 2025

Study Completion Date

August 31, 2025

Conditions

Hyperlipidemia

Interventions

DRUG

HRS-1301

HRS-1301.

DRUG

HRS-1301 placebo

HRS-1301 placebo.

Trial Locations (1)

510080

RECRUITING

Guangdong Provincial People's Hospital, Guangzhou

All Listed Sponsors

lead

Shandong Suncadia Medicine Co., Ltd.

INDUSTRY